In agreement with previous reports, doxorubicin, SNS-032 and AZD8055 caused significant suppression of MCL-1 expression in all tested SCLC cell lines (Fig. 3a; Supplementary Fig. 1b). This evidence concerns the gene MCL1 and small cell lung carcinoma.